Maria Symiakaki/ LinkedIn
May 29, 2026, 09:50
Maria Symiakaki: Advancing Cardiovascular Prevention at the 2026 Congress of the European Atherosclerosis Society
Maria Symiakaki, Co-Founder and Public Affairs Business Development Director at Solutions for Rare Diseases (SfRD), shared a post on LinkedIn:
“Happy to attend the 2026 Congress of the European Atherosclerosis Society.
It was an excellent opportunity for global leaders in lipidology and preventive cardiology to reconnect, exchange ideas, and explore the future of cardiovascular prevention and lipid management.
Key highlights included the release of the new EAS consensus on pediatric familial hypercholesterolemia (FH), as well as advances in global lipid clinic networks.
Importantly, patient voices continue to play a central role in shaping cardiovascular health policy and care pathways across Europe.”
Stay updated with Hemostasis Today.
-
Aug 31, 2026, 05:35Does LDL Cholesterol Influence VTE Risk? – Ordo Fraterna Fibonacci
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients
-
Aug 31, 2026, 04:28Reza Hafidz Irawan։ Automated Antibody Titration With Erytra Eflexis
-
Aug 31, 2026, 04:17Safa Chenganath: Stenosis vs Thrombosis – Hemodialysis Vascular Access
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session